Potential biomarkers for malignant melanoma

doi:10.5314/wjd.v2.i4.44

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 4

This Article

(0) (0) (0)

Peer-Review Report of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7173)

All Articles published online

Item

Count

PDF

513

HTML

3605

Figures (1-1)

494

Sum=4612

Publishing Process of This Article

Item

Count

Browse

1279

Download

1285

Sum=2564

Nov 2, 2013 (publication date) through May 20, 2026

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Dermatology

ISSN

2218-6190

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Minireviews

World J Dermatol. Nov 2, 2013; 2(4): 44-50
Published online Nov 2, 2013. doi: 10.5314/wjd.v2.i4.44

Open in New Tab Full Size Figure Download Figure

Figure 1 Many biological markers are related to different aspects (such as diagnosis, progression, increased risk of metastasis, recurrence, survival, response to treatment and even tumor thickness) of malignant melanomas.

Citation: Wang YN, Yamamoto Y, Furukawa F. Potential biomarkers for malignant melanoma. World J Dermatol 2013; 2(4): 44-50
URL: https://www.wjgnet.com/2218-6190/full/v2/i4/44.htm
DOI: https://dx.doi.org/10.5314/wjd.v2.i4.44

Wang YN, Yamamoto Y, Furukawa F. Potential biomarkers for malignant melanoma. World J Dermatol 2013; 2(4): 44-50 [DOI: 10.5314/wjd.v2.i4.44]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.